Markenrecherche nach Regeneron Pharmaceuticals Inc. · TMDB

Stattdessen suchen nach Regeneron Pharmaceuticals (413 Ergebnisse)

Marken vergleichen

Klasse(n)

44

Regeneron Pharmaceuticals, Inc.

27.02.2020

-

-

NOTICE OF ALLOWANCE - ISSUED

544

Regeneron Pharmaceuticals, Inc.

23.01.2020

-

-

NOTICE OF ALLOWANCE - ISSUED

44

Regeneron Pharmaceuticals, Inc.

23.01.2020

-

-

NOTICE OF ALLOWANCE - ISSUED

42

Regeneron Pharmaceuticals, Inc.

13.01.2020

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

13.01.2020

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

16.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

10.12.2019

-

-

ABANDONED - EXPRESS

5

Regeneron Pharmaceuticals, Inc.

10.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

10.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

10.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren

5

Regeneron Pharmaceuticals, Inc.

05.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

44

Regeneron Pharmaceuticals, Inc.

05.12.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

44

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

44

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

44

Regeneron Pharmaceuticals, Inc.

15.11.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

29.08.2019

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

5

Regeneron Pharmaceuticals, Inc.

29.08.2019

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

5

Regeneron Pharmaceuticals, Inc.

29.08.2019

-

-

FIRST EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

29.08.2019

-

-

FIRST EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

23.08.2019

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

5

Regeneron Pharmaceuticals, Inc.

23.08.2019

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

5

Regeneron Pharmaceuticals, Inc.

23.08.2019

-

-

FIRST EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

23.08.2019

-

-

FIRST EXTENSION - GRANTED

42

Regeneron Pharmaceuticals, Inc.

21.08.2019

-

-

SU - NON-FINAL ACTION - MAILED

5

Regeneron Pharmaceuticals, Inc.

17.08.2019

-

-

NOTICE OF ALLOWANCE - ISSUED

5

Regeneron Pharmaceuticals, Inc.

12.07.2019

-

-

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

REGENERON ON TARGET

5

Regeneron Pharmaceuticals, Inc.

31.05.2019

-

-

FIRST EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

12.02.2019

-

-

ABANDONED - NO STATEMENT OF USE FILED

5

Regeneron Pharmaceuticals, Inc.

12.02.2019

-

-

SECOND EXTENSION - GRANTED

31

Regeneron Pharmaceuticals, Inc.

04.01.2019

-

-

ABANDONED - NO STATEMENT OF USE FILED

44

Regeneron Pharmaceuticals, Inc.

14.12.2018

-

-

THIRD EXTENSION - GRANTED

44

Regeneron Pharmaceuticals, Inc.

14.12.2018

-

-

THIRD EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

26.09.2018

-

-

FIRST EXTENSION - GRANTED

5

Regeneron Pharmaceuticals, Inc.

26.09.2018

-

-

FIRST EXTENSION - GRANTED

YOUR RA MOMENTS

44

Regeneron Pharmaceuticals, Inc.

13.03.2018

-

-

ABANDONED - NO STATEMENT OF USE FILED

RIGHT ON TARGET

5

Regeneron Pharmaceuticals, Inc.

24.01.2018

-

-

FOURTH EXTENSION - GRANTED

REGENERON ON TARGET

42

Regeneron Pharmaceuticals, Inc.

24.01.2018

-

-

ABANDONED - AFTER EX PARTE APPEAL

Suchergebnisse 121 - 161 von 407

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.